156 related articles for article (PubMed ID: 37596654)
41. Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma.
Huang X; Tan J; Chen M; Zheng W; Zou S; Ye X; Li Y; Wu M
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371463
[TBL] [Abstract][Full Text] [Related]
42. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
PeerJ; 2022; 10():e14432. PubMed ID: 36518297
[TBL] [Abstract][Full Text] [Related]
43. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
44. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
[TBL] [Abstract][Full Text] [Related]
45. Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis.
Wu L; Liao W; Wang X; Zhao Y; Pang J; Chen Y; Yang H; He Y
Bioengineered; 2021 Dec; 12(2):10302-10318. PubMed ID: 34709970
[TBL] [Abstract][Full Text] [Related]
46. Integrative Multi-Omics Analysis of Identified Ferroptosis-Marker RPL8 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Liver Cancer.
Fan S; Zhang S; Kong D; Wang H; Shi Y; Wang Z; Zheng H
Comb Chem High Throughput Screen; 2023; 26(7):1298-1310. PubMed ID: 36017842
[TBL] [Abstract][Full Text] [Related]
47. Systematic Analyses of the Role of the Reader Protein of
Shao XY; Dong J; Zhang H; Wu YS; Zheng L
Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
[TBL] [Abstract][Full Text] [Related]
48. Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma.
Li S; Xue P; Diao X; Fan QY; Ye K; Tang XM; Liu J; Huang ZY; Tang QH; Jia CY; Xin R; Lv ZW; Liu JB; Ma YS; Fu D
J Adv Res; 2023 Dec; 54():133-146. PubMed ID: 36716957
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
Han X; Long W; Liu Y; Xu J
Front Surg; 2022; 9():985034. PubMed ID: 36338652
[TBL] [Abstract][Full Text] [Related]
50. Dopamine down-regulation of protein L-isoaspartyl methyltransferase is dependent on reactive oxygen species in SH-SY5Y cells.
Ouazia D; Levros LC; Rassart E; Desrosiers RR
Neuroscience; 2014 May; 267():263-76. PubMed ID: 24631677
[TBL] [Abstract][Full Text] [Related]
51. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
52. The protective role of protein L-isoaspartyl (D-aspartate) O-methyltransferase for maintenance of mitochondrial morphology in A549 cell.
Ogasawara M; Otani M; Takano M; Shudou M; Inaba Y; Nirasawa S; Takahashi S; Kiyoi T; Tanaka Y; Kameda K; Kunugita N; Maeyama K; Sano K; Yamashita M; Yamauchi K
Exp Lung Res; 2016 Jun; 42(5):245-62. PubMed ID: 27327778
[TBL] [Abstract][Full Text] [Related]
53. MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K-AKT-β-catenin pathways.
Xie L; Dai H; Li M; Yang W; Yu G; Wang X; Wang P; Liu W; Hu X; Zhao M
J Cell Mol Med; 2019 May; 23(5):3386-3401. PubMed ID: 30793486
[TBL] [Abstract][Full Text] [Related]
54. NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway.
Mu S; Tian Q; Shen L
Technol Health Care; 2024 Jan; ():. PubMed ID: 38251077
[TBL] [Abstract][Full Text] [Related]
55. The mechanism of LSM2 in the progression of live hepatocellular carcinoma was analyzed based on bioinformatics.
Qin P; Huang H; Wang J; Jiang T; Zeng N; Wang Q; He Y; Zhou Y
Med Oncol; 2023 Aug; 40(9):276. PubMed ID: 37612479
[TBL] [Abstract][Full Text] [Related]
56. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.
He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM
Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229
[TBL] [Abstract][Full Text] [Related]
57. Identification of
Zheng R; Zhu HL; Hu BR; Ruan XJ; Cai HJ
World J Clin Cases; 2020 Jul; 8(14):2917-2929. PubMed ID: 32775374
[TBL] [Abstract][Full Text] [Related]
58. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
59. Characterizing
Jin X; Shi H; Li Z; Li H; Ma H; Shi X
J Oncol; 2022; 2022():2717056. PubMed ID: 36213837
[TBL] [Abstract][Full Text] [Related]
60. G6PD and machine learning algorithms as prognostic and diagnostic indicators of liver hepatocellular carcinoma.
Li F; Wang B; Li H; Kong L; Zhu B
BMC Cancer; 2024 Jan; 24(1):157. PubMed ID: 38297250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
